PrestonCarpenterSprenkleMD

Surgical Oncology

Chief, Urology Service, VA Connecticut Healthcare Director, Urologic Oncology Fellowship Program Director, Prostate MR-US Fusion biopsy and Focal Therapy in Prostate Cancer Programs

Join to view full profile

Dr. Sprenkle is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sprenkle's full profile

Already have an account?

Office
330 Cedar St
Department Of Urology, Rm 315b
New Haven, CT 06520
Phone+1 203-785-2052

Fax+1 203-785-4043

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2009 - 2011
New York Presbyterian Hospital (Columbia Campus)Residency, Urology, 2005 - 2009
New York Presbyterian HospitalInternship, Transitional Year, 2004 - 2005
Columbia University Vagelos College of Physicians and SurgeonsClass of 2004
Stanford UniversityBA, Human Biology, 1998

Certifications & Licensure

CA State Medical License 2012 - Present
FL State Medical License 2022 - Present
CT State Medical License 2012 - 2026
PA State Medical License 2011 - 2014
NY State Medical License 2005 - 2013
American Board of Urology Urology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014

Clinical Trials

Prostate Cancer Screening in Men With Germline BRCA2 Mutations Start of enrollment: 2014 May 01
Completed
MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research Start of enrollment: 2013 Jul 01
Recruiting
Active Surveillance in Prostate Cancer, Imaging to Detect Radiographic Progression as an Endpoint (ASPIRE) Start of enrollment: 2015 Apr 01
Active, not recruiting
Study to Evaluate 99mTc-MIP-1404 SPECT/CT Imaging in Men With Biopsy Proven Low-Grade Prostate Cancer Start of enrollment: 2015 Dec 01
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

Comparative Performance of Machine Learning Models in Reducing Unnecessary Targeted Prostate Biopsies.
Fuyao Chen, Roxana Esmaili, Ghazal Khajir, Tal Zeevi, Moritz Gross
European Urology Oncology. 2025-02-08
1 citations
Prostate-specific antigen screening for prostate cancer: Diagnostic performance, clinical thresholds, and strategies for refinement.
Vinaik M Sundaresan, Shayan Smani, Pawel Rajwa, Joseph Renzulli, Preston C Sprenkle
Urologic Oncology. 2025-01-01
Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PI-RADS 5 findings on prostate MRI.
Vinaik Mootha Sundaresan, Lindsey Webb, Maximilian Rabil, Aleksandra Golos, Ryan Sutherland
Urologic Oncology. 2024-12-19

Press Mentions

Focal Therapy Society and Society of Urologic Robotic Surgeons September 19–21, 2024 Washington, DCDecember 12th, 2024
TULSA #50: Marking a MilestoneFebruary 28th, 2024
Active Surveillance: Optimizing the Quality of Life in Men with Localized Prostate Cancer - Preston Sprenkle & Randy VinceApril 14th, 2023
Join now to see all